Treating Neuroendocrine Prostate Cancer
William K. Oh, MD, explores neuroendocrine prostate cancer, emphasizing its increasing prevalence and aggressive nature.
Read More
Icahn School of Medicine at Mount Sinai
Transperineal Prostate Biopsy in the Office Setting Anesthetic Considerations
Michael A. Gorin, MD, shares his transperineal prostate biopsy procedure under local anesthesia in the office setting.
Read More
Hydrogel Rectal Spacer: Radiopaque vs. Non-radiopaque
Richard G. Stock, MD, explores the role of rectal spacers in reducing gastrointestinal toxicity during prostate cancer radiotherapy.
Read More
Radiation Dose and Hormone Therapy: How Much is Enough?
Nelson N. Stone, MD, balances the radiation dose and hormonal therapy in managing intermediate- and high-risk prostate cancer.
Read More
Adaptive Radiotherapy
In this 23-minute presentation, Richard D. Stock, MD, explores integrating artificial intelligence in radiation oncology, focusing on adaptive radiation therapy (ART). Three categories of ART—offline, online, and real-time—are detailed, explaining their respective timelines, imaging technologies, and resource requirements. The discussion critically evaluates ART in prostate cancer, where anatomical shifts due to bladder or rectal changes can influence treatment accuracy.
Examples of imaging technologies like MRI and PET scans are discussed for their contributions to ART’s precision and potential to adapt treatment based on tumor shrinkage or biological response. Comparative studies from the Netherlands and other institutions demonstrate ART’s ability to refine target margins, decrease normal tissue exposure, and predict patient outcomes more accurately.
As ART shows promise in improving treatment precision, Dr. Stock emphasizes its potential for advancing radiation oncology, driven by technological innovation and ongoing research.
Read More